Barinthus Biotherapeutics PLC banner

Barinthus Biotherapeutics PLC
NASDAQ:BRNS

Watchlist Manager
Barinthus Biotherapeutics PLC Logo
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Watchlist
Price: 0.583 USD -4.43% Market Closed
Market Cap: $23.8m

Intrinsic Value

The intrinsic value of one BRNS stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.583 USD, Barinthus Biotherapeutics PLC is hidden .

BRNS Intrinsic Value
HIDDEN
Show

Valuation History
Barinthus Biotherapeutics PLC

Intrinsic Value History
Dive into the past to invest in the future

BRNS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BRNS is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BRNS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BRNS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Barinthus Biotherapeutics PLC.

Explain Valuation
Alternatives to BRNS

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Barinthus Biotherapeutics PLC

Wall St
Price Targets

Dividends

Barinthus Biotherapeutics PLC
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

What is the Intrinsic Value of one BRNS stock?

The intrinsic value of one BRNS stock under the Base Case scenario is hidden USD.

Is BRNS stock undervalued or overvalued?

Compared to the current market price of 0.583 USD, Barinthus Biotherapeutics PLC is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett